Sort
64,565 grants matching “drug discovery”
Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications
$930,433Connie S Lebakken · Stem Pharm, Inc. · R44 · FY2021 · ES
Molecular Pathogenesis of Neoplasia
$930,329Russell Lonser · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression
$930,000Patrick Sung · University Of Texas Hlth Science Center · R35 · FY2025 · CA
Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression
$930,000Patrick Sung · University Of Texas Hlth Science Center · R35 · FY2021 · CA
A High Throughput Biofilm Assay System
$929,976Cristian Ionescu-Zanetti · Fluxion Biosciences, Inc. · R44 · FY2009 · GM
Optimized Ratiometric Voltage-Sensitive Dyes for Cardiac Research, Safety Pharmacology
$929,918Corey Acker · Potentiometric Probes, Llc · R44 · FY2024 · GM
Designer Drugs: The Emerging Face of Drug Abuse
$929,824Marilyn A Huestis · National Institute On Drug Abuse · ZIA · FY2014 · DA
High Sensitivity NMR Spectrometer with Cryoprobe
$929,724Joseph M Fox · University Of Delaware · S10 · FY2019 · OD
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform
$929,651Nathan Yee · Tambo, Inc. · R44 · FY2024 · TR
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1
$929,591Robert Daniel Toto · Ut Southwestern Medical Center · KL2 · FY2014 · TR
Tetracycline derivatives as SMN2 mRNA splicing modifiers for treatment of SMA.
$929,373Paul J Higgins · Paratek Pharmaceuticals · U01 · FY2009 · NS
Tetracycline derivatives as SMN2 mRNA splicing modifiers for treatment of SMA.
$929,373Paul Higgins · Paratek Pharmaceuticals · U01 · FY2009 · NS
Disease Modifying Biologics for Rheumatoid Arthritis
$929,079Rekha Bansal · Novelmed Therapeutics, Inc. · R44 · FY2011 · AG
Specificity Screening Drug Development Tool for Biotherapeutic Safety
$929,016Benjamin Jacob Doranz · Integral Molecular · SB1 · FY2025 · GM
Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs
$928,854Brian Tsuji · State University Of New York At Buffalo · R01 · FY2016 · AI
Attacking stress tolerance in cancer
$928,703David A Cheresh · University Of California, San Diego · R35 · FY2022 · CA
Developmental Biology and Solid Tumor
$928,558Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2014 · CA
Development of Sudaxine for the Treatment of Opioid Induced Respiratory Depression (OIRD) in the Peri-operative Hospital Setting
$928,464James N Bates · Atelerix Life Sciences Inc. · R44 · FY2023 · HL
Identifying Genetic Variants Associated with Opioid Overdose Mortality
$928,386Elliot C Nelson · Washington University · R01 · FY2018 · DA
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
$928,378Marc L Peters-Golden · University Of Michigan At Ann Arbor · R35 · FY2022 · HL
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
$928,378Marc L Peters-Golden · University Of Michigan At Ann Arbor · R35 · FY2019 · HL
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
$928,378Marc L Peters-Golden · University Of Michigan At Ann Arbor · R35 · FY2021 · HL
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
$928,378Marc L Peters-Golden · University Of Michigan At Ann Arbor · R35 · FY2020 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing (COVID-19 Competitive Revision)
$928,351Donald E Ingber · Harvard University · UH3 · FY2020 · HL
Tackling Undruggable Cancer Targets using Chemoproteomic Platforms
$928,230Daniel Nomura · University Of California Berkeley · R35 · FY2022 · CA